ES2104370T3 - Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion. - Google Patents

Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion.

Info

Publication number
ES2104370T3
ES2104370T3 ES94911181T ES94911181T ES2104370T3 ES 2104370 T3 ES2104370 T3 ES 2104370T3 ES 94911181 T ES94911181 T ES 94911181T ES 94911181 T ES94911181 T ES 94911181T ES 2104370 T3 ES2104370 T3 ES 2104370T3
Authority
ES
Spain
Prior art keywords
hydrogen
arylalkylaminobencil
aminopropionamides
derivatives
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94911181T
Other languages
English (en)
Inventor
Mario Varasi
Philippe Dostert
Paolo Pevarello
Alberto Bonsignori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Application granted granted Critical
Publication of ES2104370T3 publication Critical patent/ES2104370T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EN LA INVENCION SE PRESENTAN NUEVOS COMPUESTOS DE LA FORMULA (I) EN LA QUE N ES UN ENTERO DE 1 A 4; CADA R Y R1, QUE PUEDEN SER IGUALES O DIFERENTES, ES HIDROGENO, HALOGENO, TRIFLUOMETILO O ALCOXI C1-C4; R2 ES HIDROGENO O ALQUILO C1-C4; Y UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS; Y EN LA QUE CUANDO, R ES HIDROGENO, R1 ES HIDROGENO O HALOGENO Y N ES UNO, AL MISMO TIEMPO, ENTONCES R2 ES DISTINTO DE HIDROGENO O METILO; Y DE LA FORMULA (IA) EN LA QUE R3 ES HALOGENO, Y UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS, QUE SON ACTIVOS EN EL SISTEMA NERVIOSO CENTRAL (CNS) Y SE PUEDEN UTILIZAR EN METODOS DE TERAPIA COMO AGENTES ANTIEPILEPTICOS, ANTI-PARKINSON, NEUROPROTECTORES, ANTIDEPRESIVOS, ANTIESPASTICOS E HIPNOTICOS.
ES94911181T 1993-04-01 1994-03-15 Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion. Expired - Lifetime ES2104370T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939306899A GB9306899D0 (en) 1993-04-01 1993-04-01 Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
ES2104370T3 true ES2104370T3 (es) 1997-10-01

Family

ID=10733226

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94911181T Expired - Lifetime ES2104370T3 (es) 1993-04-01 1994-03-15 Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion.

Country Status (21)

Country Link
US (1) US5449692A (es)
EP (1) EP0648202B1 (es)
JP (1) JP3542600B2 (es)
KR (1) KR950701905A (es)
CN (1) CN1035939C (es)
AT (1) ATE152442T1 (es)
AU (1) AU667169B2 (es)
CA (1) CA2136008C (es)
DE (1) DE69402935T2 (es)
DK (1) DK0648202T3 (es)
ES (1) ES2104370T3 (es)
FI (1) FI945582A (es)
GB (1) GB9306899D0 (es)
GR (1) GR3024150T3 (es)
HU (1) HUT70944A (es)
IL (1) IL108970A0 (es)
NZ (1) NZ263183A (es)
PL (1) PL306538A1 (es)
RU (1) RU94046144A (es)
WO (1) WO1994022809A1 (es)
ZA (1) ZA941964B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515412D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
CA2310664C (en) * 1997-11-21 2008-03-11 Euro-Celtique S.A. Substituted 2-aminoacetamides and the use thereof
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
DK1169060T3 (da) * 1999-04-09 2006-01-16 Euro Celtique Sa Natriumkanalblokkerpræparater og anvendelse deraf
MXPA04002009A (es) 2001-09-03 2004-07-08 Newron Pharm Spa Composicion farmaceutica que comprende gabapentina o un analogo de la misma y alfa-aminoamida y su uso como analgesico.
EP1438956A1 (en) 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
KR101277520B1 (ko) * 2004-09-10 2013-06-21 뉴론 파마슈티칼즈 에스. 피. 에이. （할로벤질옥시）벤질아미노－프로판아미드를 포함하는 선택적 나트륨 및／또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
AR057982A1 (es) * 2005-10-26 2008-01-09 Boehringer Ingelheim Int Compuestos de [hetero) arilo con actividad antagonista de mch y composicion farmaceutica que comprende estos compuestos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140748A (en) * 1966-06-23 1969-01-22 Ici Ltd New carboxylic acid derivatives
US4049663A (en) * 1972-06-06 1977-09-20 Allen & Hanburys Limited Ethylene diamine derivatives
DE3050800C2 (es) * 1979-03-22 1989-06-22 Continental Pharma Inc., Bruessel/Bruxelles, Be
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
US4728668A (en) * 1985-04-16 1988-03-01 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4725619A (en) * 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation

Also Published As

Publication number Publication date
JPH08504828A (ja) 1996-05-28
RU94046144A (ru) 1996-09-27
DK0648202T3 (da) 1997-10-27
CA2136008C (en) 2005-06-14
IL108970A0 (en) 1994-06-24
EP0648202B1 (en) 1997-05-02
ZA941964B (en) 1994-10-19
PL306538A1 (en) 1995-04-03
HU9403809D0 (en) 1995-02-28
ATE152442T1 (de) 1997-05-15
DE69402935D1 (de) 1997-06-05
FI945582A0 (fi) 1994-11-28
AU6377694A (en) 1994-10-24
EP0648202A1 (en) 1995-04-19
CN1035939C (zh) 1997-09-24
CA2136008A1 (en) 1994-10-13
AU667169B2 (en) 1996-03-07
CN1104018A (zh) 1995-06-21
KR950701905A (ko) 1995-05-17
GB9306899D0 (en) 1993-05-26
HUT70944A (en) 1995-11-28
GR3024150T3 (en) 1997-10-31
NZ263183A (en) 1996-02-27
DE69402935T2 (de) 1997-11-20
US5449692A (en) 1995-09-12
FI945582A (fi) 1994-11-28
WO1994022809A1 (en) 1994-10-13
JP3542600B2 (ja) 2004-07-14

Similar Documents

Publication Publication Date Title
NO306237B1 (no) Anvendelse av xantinderivater som antidepressive midler
FI961914A (fi) Lyhytvaikutteiset dihydropyridiinit
ES2122253T3 (es) Derivados (arilalcoxibencil)aminopropanamidicos sustituidos, su preparacion y su utilizacion como agentes antiepilepticos, neuroprotectores y antidepresivos.
ES2105286T3 (es) Derivados de etanolamina que tienen actividades simpatomimetica y anti-polaquiuria.
ES2104370T3 (es) Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion.
ATE17346T1 (de) Benzamido-derivate.
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
DE69330601D1 (de) Serotoninergische ergolin derivate
DK0581904T3 (da) Fremgangsmåde til inhibering af fibrose
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
IE802682L (en) Oxazoline derivatives
DK0651747T3 (da) Carbostyrilderivater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 648202

Country of ref document: ES